HBMCX
Price
$22.31
Change
-$0.14 (-0.62%)
Updated
Sep 25 closing price
Net Assets
781.87M
JDMAX
Price
$138.26
Change
-$1.74 (-1.24%)
Updated
Sep 25 closing price
Net Assets
23.75B
Interact to see
Advertisement

HBMCX vs JDMAX

Header iconHBMCX vs JDMAX Comparison
Open Charts HBMCX vs JDMAXBanner chart's image
Hartford MidCap HLS IB
Price$22.31
Change-$0.14 (-0.62%)
VolumeN/A
Net Assets781.87M
Janus Henderson Enterprise A
Price$138.26
Change-$1.74 (-1.24%)
VolumeN/A
Net Assets23.75B
HBMCX vs JDMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HBMCX vs. JDMAX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBMCX is a Hold and JDMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JDMAX has more cash in the bank: 23.7B vs. HBMCX (782M). JDMAX pays higher dividends than HBMCX: JDMAX (0.75) vs HBMCX (0.00). HBMCX was incepted earlier than JDMAX: HBMCX (26 years) vs JDMAX (16 years). JDMAX (1.14) is less costly to investors than HBMCX (0.99). HBMCX is a more actively managed with annual turnover of: 75.00 vs. JDMAX (15.00). HBMCX has a lower initial minimum investment than JDMAX: HBMCX (0) vs JDMAX (2500). JDMAX annual gain was more profitable for investors over the last year : -0.21 vs. HBMCX (-14.31). JDMAX return over 5 years is better than : 3.90 vs. HBMCX (-31.40).
HBMCXJDMAXHBMCX / JDMAX
Total Expense Ratio0.991.1487%
Annual Report Gross Expense Ratio0.991.1487%
Fund Existence26 years16 years-
Gain YTD-15.2194.790-318%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets782M23.7B3%
Annual Yield % from dividends0.000.75-
Returns for 1 year-14.31-0.216,884%
Returns for 3 years1.6320.438%
Returns for 5 years-31.403.90-805%
Returns for 10 years-28.8171.78-40%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRNX35.890.71
+2.02%
Crinetics Pharmaceuticals
SFHG0.720.01
+1.20%
Samfine Creation Holdings Group Ltd
VLTO104.49-1.14
-1.08%
Veralto Corp
TK8.55-0.15
-1.72%
Teekay Corporation Ltd
CCCC2.19-0.23
-9.50%
C4 Therapeutics